Companies: 10,795·Total market cap: $144.5T
Ernexa Therapeutics Inc.

Ernexa Therapeutics Inc.

ERNANASDAQHealthcare● Active
$7.62
+$0.23(+3.11%)
Market Cap$2393625
P/E Ratio—
52W High$71.5
52W Low$3.18
SEC Filings

Ernexa Therapeutics Inc. (ERNA) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0000748592 · ERNA · NASDAQ · as of Jun 9, 2026

Filing snapshot

1,000+
Total Filings
SCHEDULE 13G/A
Latest Form
2026-05-20
Most Recent
1991
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0000748592 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-13
Fiscal Year End
Mar 13, 2026
Accession No.
0001493152-26-010102
Primary Document
form10-k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0000748592 · Accession 0001493152-26-010102

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-11
View 10-Q on SEC
8-KCurrent Report
8-K
2026-05-04Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-20
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-14
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-14
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-13
View
ARSARS
ARS
2026-05-11
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-05-11
View
DEF 14AProxy Statement
DEF 14A
2026-05-11
View
10-QQuarterly Report
10-Q
2026-05-11
View
8-KCurrent Report
8-K
2026-05-04
View
DEF 14CDEF 14C
DEF 14C
2026-04-13
View
PRE 14CPRE 14C
PRE 14C
2026-04-01
View
EFFECTEFFECT
EFFECT
2026-03-30
View
CORRESPCORRESP
CORRESP
2026-03-26
View
Showing 1–15 of 674 filingsForm 4 / 144 hidden· 1000 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0000748592  |  Exchange: NASDAQ · Healthcare

Ernexa Therapeutics Inc. (NASDAQ: ERNA) has submitted 1,000+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1991. As a Healthcare sector company with CIK 0000748592, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Ernexa Therapeutics Inc.'s most comprehensive regulatory disclosure. The most recent Ernexa Therapeutics Inc. 10-K was filed on 2026-03-13 for fiscal year ending 2026. Historical ERNA 10-K annual reports are available from 2010 through 2026.

Investors researching Ernexa Therapeutics Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
MPLT SEC Filings →PMN SEC Filings →ADAP SEC Filings →LNAI SEC Filings →OSRH SEC Filings →AEON SEC Filings →MBRX SEC Filings →DWTX SEC Filings →
→ ERNA Financials→ ERNA Earnings→ ERNA Insider Trades

Frequently Asked Questions

ERNA SEC Filings · 8 questions

Ernexa Therapeutics Inc. (ERNA) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,000+ filings and access original documents at no cost. Ernexa Therapeutics Inc.'s CIK is 0000748592.

ERNA SEC filingsErnexa Therapeutics Inc. SEC documentsfind ERNA 10-K